Suspension of trading
Quotes Acorda Therapeutics OTC Markets
Stocks
ACOR
US00484M7002
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-10.00% | -99.91% |
| 13/08/24 | First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc. | CI |
| 07/08/24 | Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc. | CI |
Performance
| 1 week | -10.00% | ||
| 1 month | -87.85% | ||
| 3 months | -98.41% | ||
| 6 months | -99.90% | ||
| Current year | -99.91% | ||
| 1 year | -99.92% | ||
| 3 years | -99.98% | ||
| 5 years | -100.00% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
16,768
Free-Float
99.33 %
Free-Float capitalization (USD)
16,660
Indicators
Moving average 5 days
0.0159
Moving average 100 days
0.5599
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -10.00% | -99.92% | -99.98% | 16.77K | |
| -3.25% | +12.81% | +52.96% | +88.86% | 64.9B | |
| +0.69% | -2.81% | +25.84% | +68.41% | 54.05B | |
| -1.07% | -1.79% | -18.07% | -7.42% | 23.16B | |
| +33.86% | +30.60% | +19.14% | +506.08% | 21.46B | |
| +1.87% | +5.08% | +29.88% | -7.94% | 21.25B | |
| -0.79% | +0.54% | +31.17% | -25.84% | 17.94B | |
| -3.37% | +19.44% | +211.98% | +369.13% | 17.03B | |
| +3.29% | +2.09% | +17.32% | +586.49% | 14.99B | |
| -7.94% | -6.74% | +38.42% | +157.78% | 14.25B | |
| Average | +2.58% | +3.37% | +30.87% | +163.56% | 24.9B | |
| Weighted average by Cap. | +1.72% | +3.64% | +41.91% | +147.95% |
Historical Quotes: Acorda Therapeutics
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- ACOR.Q Stock
- ACOR Stock
- Quotes Acorda Therapeutics
Select your edition
All financial news and data tailored to specific country editions
